Actoprotective activity research of 2-((5-(2-bromophenyl)-4-substituted-4H-1,2,4-triazole-3-yl)thio)acetates

Authors

  • A. A. Safonov Zaporizhzhia State Medical University, Ukraine,
  • A. V. Nevmyvaka Zaporizhzhia State Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2409-2932.2020.2.207196

Keywords:

actoprotective activity, 1, 2, 4-triazole, acids, salts, heterocyclic compounds

Abstract

 

Severe fatigue can occur due to overwork, lack of exercise, depression, insomnia, etc. It should be understood that fatigue, weakness, both emotional and physical, is not a disease. Often, actoprotective substances are used to reduce fatigue. To search for new substances with a different spectrum of pharmacological activity, 1,2,4-triazole derivatives have proven themselves well.

The aim of work was to investigate actoprotective activity among previously synthesized 2-((5-(2-bromophenyl)-4-substituted-4H-1,2,4-triazole-3-yl)thio)acetates.

Materials and methods. The compounds used to study pharmacological activity were synthesized at the Department of Natural Sciences for International Students and Toxicological Chemistry ZSMU. White nonlinear rats weighing 200–260 g of 7 animals per group were used to study the actoprotective activity of 2-((5-(2-bromophenyl)-4-substituted-4H-1,2,4-triazole-3-yl)thio)acetates. As a method for the study of pharmacological activity was used the method of forced swimming with a load of 10 % by weight of the rat. Statistical results were calculated using Kolmogorov–Smirnov test and Shapiro-Wilk test.

Results. Compounds Ia, Ib, IIb, IIk, IIj had been found to have a moderate actoprotective effect. But none compound had exceeded the comparison drug. Some conclusions were drawn regarding the dependence of “structure – actoprotective effect”: the most active compound was 2-aminoethanol 2-((5-(2-bromophenyl)-4-ethyl-4H-1,2,4-triazole-3-yl)thio)acetate (IIj); conversion to 2-((5-(2-bromophenyl)-4-substituted-4H-1,2,4-triazole-3-yl)thio)acetate salts and selection as sodium, potassium, or 2-aminoethanol cations was resulted in to increase the actoprotective effect.

Conclusions. As a result, the actoprotective activity of 18 new 2-((5-(2-bromophenyl)-4-substituted-4H-1,2,4-triazole-3-yl)thio)acetates was investigated. Some conclusions were drawn regarding the dependence of “structure – actoprotective effect”.

References

Shcherbak, M. A., Kaplaushenko, A. G., Maletskiy, N. N., & Sharaya, Ye. A. (2014). Issledovaniya po sozdaniyu lekarstvennoi formy na osnove 3-(4-nitrofenil)-5-(nonilsul’fonil)-1,2,4-triazol-4-amina [The research on creation the dosage form based on 3-(4-nitrophenyl)-5-(nonylsulfonyl)-1,2,4-triazol-4-amine]. Zaporozhye Medical Journal, (4), 82-85. [in Russian]. https://doi.org/10.14739/2310-1210.2014.4.27449

Kaplaushenko, A. H. (2013). Doslidzhennia zi stvorennia novoho oryhinalnoho vitchyznianoho likarskoho zasobu na osnovi 1,2,4-triazolu [The research of creating a new original domestic drug based on 1,2,4-triazole]. Naukovyi zhurnal MOZ Ukrainy, (2), 115-121. [in Ukrainian].

Shcherbyna, R. O. (2014) Analiz farmakolohichnoi aktyvnosti pokhidnykh 1,2,4-triazolu [Analysis of pharmacological activity of 1,2,4-triazole derivatives]. Farmatsevtychnyi chasopys, (4), 145-150. [in Ukrainian].

Li, Y. S., Tian, H., Zhao, D. S., Hu, D. K., Liu, X. Y., Jin, H. W., Song, G. P., & Cui, Z. N. (2016). Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters, 26(15), 3632-3635. https://doi.org/10.1016/j.bmcl.2016.06.002

Shcherbyna, R. O., Panasenko, O. I., & Knysh, Ye. H. (2016). Vyvchennia antyoksydantnoi aktyvnosti solei 2-((4-R-3-(morfolinometylen)-4H-1,2,4-tryazol-5-il)tio)atsetatnykh kyslot [The studying of antioxidant activity of salts 2-((4-R-3-(morpholinomethylen)-4H-1,2,4-triazole-5-yl)thio)acetic acids]. Ukrainian Biopharmaceutical Journal, (1), 37-40. [in Ukrainian].

Shcherbyna, R. O., Kapelyanovych, Ye. V., Pruhlo, Ye. S., Panasenko, O. I., & Knysh, Ye. H. (2014). Doslidzhennia aktoprotektornoi aktyvnosti pokhidnykh 4-R-3-(morfolinometylen)-1,2,4-triazol-5-tiolu [The studying of actoprotective action of 4-R-3-(morpholinomethylene)-1,2,4-triazole-5-thiole derivatives]. Odeskyi medychnyi zhurnal, (6), 19-22. [in Ukrainian].

Aksyonova, I. I., Shcherbyna, R. O., Panasenko, O. I., Knysh, Ye. H., & Aksyonov, I. V. (2014). Doslidzhennia riststymuliuiuchoi aktyvnosti pokhid-nykh 1,2,4-tryazolu na prykladi nasinnia soniashnyka prostoho [The investiga-tion of growth-stimulating activity of derivatives of 1,2,4-triazole on seeds of sunflower simple] Ukrainian Biopharmaceutical Journal, (6), 78-82. [in Ukrainian].

Murty, M. S. R., Ram, K. R., Rao, R. V., Yadav, J. S., Rao, J. V., Pamanji, R., & Velatooru, L. R. (2012). Synthesis of New S-alkyla¬ted-3-mercapto-1,2,4-triazole Derivatives Bearing Cyclic Amine Moiety as Potent Anticancer Agents. Letters in Drug Design & Discovery, 9(3), 276-281. https://doi.org/10.2174/157018012799129882

Pillai, R. R., Karrouchi, K., Fettach, S., Armakovic, S., Armakovic, S. J., Brik, Y., Taoufik, J., Radi, S., Faouzi, M. E., & Ansar, M. (2019). Synthesis, spectroscopic characterization, reactive properties by DFT calculations, molecular dynamics simulations and biological evaluation of Schiff bases tethered 1,2,4-triazole and pyrazole rings. Journal of Molecular Structure, 1177, 47-54. https://doi.org/10.1016/j.molstruc.2018.09.037

Shcherbyna, R. O., Panasenko, O. I., Knysh, Ye. H., & Varynskyy, B. О. (2014). Syntez i fizyko-khimichni vlastyvosti 2-((4-R-3-(morfolinometylen)-4H-1,2,4-triazol-5-il)tio) atsetatnykh kyslot [Synthesis and physical-chemical properties of 2-((4-R-3-(morpholinomethylen)-4H-1,2,4-triazole-5yl)thio)acetic acid]. Current Issues in Pharmacy and Medicine: Science and Practice, (3), 18-21. [in Ukrainian]. https://doi.org/10.14739/2409-2932.2014.3.30016

El-Sherief, H. A. M., Youssif, B. G. M., Bukhari, S. N. A., Abdelazeem, A. H., Abdel-Aziz, M., & Abdel-Rahman, H. M. (2018). Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors. European Journal of Medicinal Chemistry, 156, 774-789. https://doi.org/10.1016/j.ejmech.2018.07.024

Samelyuk, Yu. H., & Kaplaushenko, A. H. (2015). Hostra toksychnist 5-(2-, 3-, 4-metoksyfenil, (3,4,5-trymetoksyfenil)-)-1,2,4-triazol-3-tioniv ta yikh tiopokhidnykh [Acute toxicity of 5-(2-, 3-, 4-methoxyphenyl, (3,4,5-trimethoxyphenyl)-)-1,2,4-triazole-3-thiones and their thioderivatives]. Current Issues in Pharmacy and Medicine: Science and Practice, (3), 57-60. [in Ukrainian]. https://doi.org/10.14739/2409-2932.2015.3.52660

Safonov A. A., Nevmyvaka A. V. (2020). Synthesis of novel 3-(2-bromophenyl)-4-substituted-1H-1,2,4-triazole5(4H)-thiones derivatives. Current Issues in Pharmacy and Medicine: Science and Practice, 13(1), 11-16. https://doi.org/10.14739/2409-2932.2020.1.198087

Stefanov, O. V. (Ed.). (2001). Doklinichni doslidzhennia likarskykh zasobiv [Preclinical studies of medicinal products: methodical recommendations]. Kyiv: Avicena. [in Ukrainian].

Downloads

How to Cite

1.
Safonov AA, Nevmyvaka AV. Actoprotective activity research of 2-((5-(2-bromophenyl)-4-substituted-4H-1,2,4-triazole-3-yl)thio)acetates. Current issues in pharmacy and medicine: science and practice [Internet]. 2020Jul.3 [cited 2024May24];13(2). Available from: http://pharmed.zsmu.edu.ua/article/view/207196

Issue

Section

Original research